Dr Farnaz Fahimi is a member of the Translational Antigen Discovery Research group in the Centre for Cancer Research.
Areas of interest
Childhood cancer Pancreatic cancer Sarcoma
Research group
Translational Antigen Discovery
Biography
Dr Farnaz Fahimi is a Postdoctoral Research Fellow in the Translational Antigen Discovery research group. She joined A/Prof Pouya Faridi’s lab in April 2024, with the aim of identifying novel cancer antigens and developing cutting-edge immunotherapy technologies.
Dr Fahimi completed her Bachelor and Master of Science in Biotechnology in Iran. During her master’s studies, she focused on isolating single-chain fragment variables (scFvs) against H.Pylori’s VacA toxin using phage libraries. She was awarded her PhD in 2023 at Monash University, where she focused on the development of a bispecific antibody (BsAb) targeting chemokine receptors and evaluated its synergistic efficacy in reducing resistance to checkpoint inhibitors, using mouse tumour models.
Publication highlights
